Established in 1994, Luye Life Sciences Group adopts “Professional Technology Serves Human Health” as its mission. It is committed to innovation and internationalization and has developed into a global healthcare group comprises of three core businesses, pharmaceuticals, healthcare and new technologies development and investment.
The Group's pharmaceutical unit is committed to the research, manufacturing and distribution of innovative drugs over the world. There are more than 30 listed products, spread across over 80 countries and regions around the world. The manufacturing and quality management systems follow international standards and meet international market requirements. Luye Pharma has established a global new drug research and development system. At present, there are 10 new drugs with innovative delivery technologies and antibody technologies in different stages of clinical trials in the United States, Europe and Japan. In recent years, Luye Pharma has integrated advanced global resources, built innovative platforms around the frontier fields of gene and cell technologies, and actively laid out the future.
In recent years, Luye Life Sciences has been actively expanding its international high-quality medical services industry. Luye Medical Group, a subsidiary of the Group, has nearly 50 professional healthcare institutions in Australia and Asia, covering psychology, orthopedics, oncology, cardiovascular, obstetrics & gynaecology. Luye Medical is in a strategic cooperation with Cleveland Clinic to bring about and innovate internationally leading technology, operation and management. Luye Medical has become one of the leading international private healthcare groups in the Asia- Pacific.
Luye Life Sciences is also committed to the investment and development of new technologies in life sciences. Singapore Vela Diagnostics is a leading global provider of integrated molecular diagnostics solutions with a number of world's leading diagnostic technologies. For neurology, psychiatry and oncology plus a whole range of other medical fields, Luye Life Sciences actively explores the integration across sectors, and ultimately provide innovative solutions.
In the future, Luye Life Sciences Group will be rooted in innovative drug development, led by premium healthcare services, and empowered by next generation technology research. We aspire to become one of the most respected international leaders in the life sciences field.